This message was sent to ##Email##
|
|
|
|
|
| |
Genetic Engineering & Biotechnology News
By now most people know the immense value of magnetic resonance imaging (MRI) for determining an array of diseases or disorders of the body. Yet, for all its power, MRI is only as good as the physician reading the scans, and when used to determine cancer, the physicians are only as good as the chemicals employed to distinguish healthy tissue from cancerous tumors. Now, investigators at Case Western Reserve University have developed a new MRI contrasting agent that not only pinpoints breast cancers at early stages but differentiates between aggressive and slow-growing types.
READ MORE
ACS Cancer Programs
October is Breast Cancer Awareness Month. The National Accreditation Program for Breast Centers (NAPBC) and the Commission on Cancer (CoC) encourage your program to promote Breast Cancer Awareness Month and use it as an opportunity to display and publicize your accreditation status. To help you promote this event within your program and community, the NAPBC and the CoC have created a poster that you can download and print.
Access the poster as follows:
Centers solely accredited by the NAPBC: Use the link to the Marketing Resources website provided in your performance report cover letter.
Programs that are accredited by the CoC solely and/or both the CoC and NAPBC: Go to CoC Datalinks and click on Marketing CoC Accreditation.
Please let us know about your celebration by sending photos and event information to
Susan Rubin, Business Development Manager, ACS Cancer Programs.
TIME
Being diagnosed with breast cancer can make a person feel powerless, but there are some things women can do to potentially improve how they feel throughout the process. Here are some strategies recommended by experts — and others that are still being explored — which may help improve the effectiveness and symptoms of treatment.
READ MORE
|
Promoted by
|
|
|
|
 |
Medical News Today
Researchers report that FANCM gene mutations are associated with early cancer development, as well as with toxicity to chemotherapy.
Cancer remains one of the biggest health burdens in the United States, with more than 1.6 million new cases of the disease diagnosed last year.
Genetic mutations are a major cause of cancer; they disrupt the normal processes that control cell growth, causing cells to grow out of control and form tumors. Identifying cancer-causing gene mutations is crucial for uncovering strategies to prevent, diagnose and treat cancer. And now, researchers may have added another candidate to the list: FANCM.
READ MORE
NPR
Women ages 30 to 65 may decide how often they want to get screened for cervical cancer depending on the test they choose, according new draft recommendations for cervical cancer screening from the U.S. Preventive Services Task Force (USPSTF). Testing every three years requires a Pap smear, and testing every five years requires a test for human papillomavirus (HPV), the virus that causes nearly all cervical cancers. "A woman going to her provider for a visit would want to talk with her doctor about the last time she was screened, what type of screening she had, which one to have next and what the timing of that should be," says Maureen Phipps, chair of obstetrics and gynecology at the Warren Alpert Medical School of Brown University in Providence, R.I., and a member of the task force. The draft recommendations update the 2012 USPSTF recommendations.
READ MORE
| |
PRODUCT SHOWCASE | Advertisement
|
 |
|
Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text. Click here to learn more!
|
|
ACS
Registration is now open for the American College of Surgeons Clinical Congress 2017, Oct. 22–26 in San Diego. Clinical Congress is one of the largest meetings of surgeons in the world and offers outstanding educational opportunities for every stage of your career. The theme of this year's conference is Do What's Right for the Patient.
READ MORE
Medical Xpress
St. Jude Children's Research Hospital structural biologists have deciphered how the structure of the enzyme called Abl regulates its activity, enabling the enzyme to switch itself on and off. Understanding Abl's regulation is important because a mutant form of the enzyme (Bcr-Abl) is over activated in chronic myelogenous leukemia and other cancers. Abl is a central growth-controlling switch in white blood cells. The enzyme's over activation spurs mutated cells to the uncontrolled growth of leukemia.
READ MORE
 |
|
Novodiax is soon bringing to market 10-minute fast, sensitive and simple Immunoassay (IHC) kits for in vitro diagnostic use to address unmet needs in the intraoperative surgical oncology sector. Learn More
|
|
Medical Xpress
Pediatric researchers investigating the childhood cancer neuroblastoma have identified common gene variants that raise the risk of an aggressive form of that disease. The discovery may assist doctors in better diagnosing subtypes of neuroblastoma.
READ MORE
Oncology Nurse Advisor
Intractable hiccups — also referred to as hiccoughs in the literature — can be especially problematic when treating patients with advanced cancer or in the palliative care setting. Multiple agents have been tried to treat this condition. Baclofen (Lioresal), chlorpromazine (Thorazine) and metoclopramide (Reglan) are the medications most frequently used in clinical practice for the treatment of intractable hiccups, with varying efficacy.
READ MORE
|
Promoted by
|
|
|
|
 |
AJCC
Donna Gress, RHIT, CTR, of the American Joint Committee on Cancer (AJCC) has recorded a series of webinars developed for and delivered to the National Program of Cancer Registries (NPCR) Education Training Coordinators (ETC). NPCR has agreed to share these recordings and handouts with the registrar community. These webinars provide information on the assignment of stage, clarification of classification criteria with procedure/treatment differences and special concerns and highlight:
- Exceptions for T, N and M
- When biopsy is considered clinical versus pathologic
- Review and examples of when to use blank versus X
- Details based on common questions related to the anatomic site
- Case scenario, sometimes highlighting missing or incomplete information
Click here to start reviewing the webinars.
Webinars are free. Continuing education (CE) hours were not pre-approved for these webinars.
 |
|
Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more.
|
|
Medical Xpress
The high-tech scanning techniques were enabled by funding from the British Heart Foundation (BHF) and could reveal whether chemotherapy is damaging a person's heart before any symptoms appear. Doxorubicin is a commonly used type of chemotherapy drug that slows or stops the growth of cancer cells by blocking an enzyme that cancer cells need to divide and grow. The drug is used to treat a wide variety of cancers, including breast cancer, ovarian cancer, bladder cancer and Hodgkin's lymphoma, and has drastically improved survival rates from these diseases.
READ MORE
Modern Medicine
After years focused on innovative payment models to improve PCP-led care coordination, attention is turning to how to engage specialists, who preside over the care of some of our nation’s sickest and most vulnerable patients. One especially critical frontier is oncology. The costs of battling cancer continue to rise unabated, with systemic spend forecast to grow up to 39 percent between 2010 and 2020, reaching $173 billion. Meanwhile, the average price of cancer drugs is also increasing, doubling over the past decade to more than $10,000 per month.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The CoC and NAPBC do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons, the CoC and the NAPBC.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
